Chronicle Bio
PrivateLast Round
Seed Round
Jul 7, 2026
Total Funding Raised
$5.36M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Chronicle Bio is a biotechnology company that has developed a data-driven healthcare platform designed to accelerate drug discovery for neuroimmune conditions.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Medical AI, Biotechnology, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Data as a Service, Subscription SaaS, Services & Consulting
AI Layer
Foundation
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Chronicle Bio Comparables
Compare Chronicle Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PrecisionLife | 74% | |
| Betteromics | 70% | |
| IMU Biosciences | 69% |
Chronicle Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Jul 7, 2026 | ||||
| Seed | Jan 1, 2026 |
Chronicle Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Wisdom Ventures | Seed Round, Seed |
| Electric Capital | Seed Round, Seed |
| Tarsadia Investments | Seed Round, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 7, 2026
Raised $10.3M in a seed funding round.
- Jan 1, 2026
$5.36M round led by Tarsadia Investments and Electric Capital.
Recent news
Latest coverage and updates
- receives_financingJul 1, 2026
ChronicleBio receives financing of $15M.
Chronicle Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Chronicle Bio's valuation, stock price, and market status.
Is Chronicle Bio a public or private company?
Chronicle Bio is a private company.
What is the current stock price of Chronicle Bio?
Chronicle Bio is a private company with no public stock price. No recent secondary market data is available.
How much is Chronicle Bio worth (valuation)?
Valuation information for Chronicle Bio is not publicly available.
Can I buy Chronicle Bio stock?
Chronicle Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Chronicle Bio's last funding round?
Chronicle Bio's most recent funding round was Seed Round on July 7, 2026.
Who are the main investors in Chronicle Bio?
Key investors in Chronicle Bio include Wisdom Ventures, Electric Capital, Tarsadia Investments.
Will Chronicle Bio IPO soon?
No public IPO plans have been announced for Chronicle Bio.
How can I track Chronicle Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Chronicle Bio's secondary market activity and sign up for updates.